TMC-GCID Publications

Found 63 results
2023
Xing Y, Clark JR, Chang JD, Chirman DM, Green S, Zulk JJ, et al.. Broad protective vaccination against systemic Escherichia coli with autotransporter antigens. PLoS Pathog. 2023 ;19(2):e1011082.
B Ayyar V, Ettayebi K, Salmen W, Karandikar UC, Neill FH, Tenge VR, et al.. CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection. Nat Commun. 2023 ;14(1):1148.
Carter H, Clark J, Carlin LG, Vaughan E, Rajan A, Olvera A, et al.. Functional Genomics of Gastrointestinal Isolated from Patients with Cancer and Diarrhea. bioRxiv. 2023 ;.
Majidian S, Agustinho DPaiva, Chin C-S, Sedlazeck FJ, Mahmoud M. Genomic variant benchmark: if you cannot measure it, you cannot improve it. Genome Biol. 2023 ;24(1):221.
Avadhanula V, Creighton C, Ferlic-Stark L, Sucgang R, Zhang Y, Nagaraj D, et al.. Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load. Res Sq. 2023 ;.
Su L, Huang W, Neill FH, Estes MK, Atmar RL, Palzkill T. Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response. NPJ Vaccines. 2023 ;8(1):87.
Poplaski V, Sawyer F, Blutt SE. THE SMALL INTESTINAL MICROBIOME: VIBING WITH INTESTINAL STEM CELLS. Microbiota Host. 2023 ;1(1).
Lewis MA, Cortés-Penfield NW, Ettayebi K, Patil K, Kaur G, Neill FH, et al.. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 ;67(10):e0063623.
Lewis MA, Cortés-Penfield NW, Ettayebi K, Patil K, Kaur G, Neill FH, et al.. A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide. bioRxiv. 2023 ;.
Tisza M, Cregeen SJavornik, Avadhanula V, Zhang P, Ayvaz T, Feliz K, et al.. Wastewater sequencing reveals community and variant dynamics of the collective human virome. Nat Commun. 2023 ;14(1):6878.
2022
Menon VK, Okhuysen PC, Chappell CL, Mahmoud M, Mahmoud M, Meng Q, et al.. Fully resolved assembly of Cryptosporidium parvum. Gigascience. 2022 ;11.
DiNardo AR, Gandhi T, Heyckendorf J, Grimm SL, Rajapakshe K, Nishiguchi T, et al.. Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes. Eur Respir J. 2022 ;60(3).
Lin S-C, Haga K, Zeng X-L, Estes MK. Generation of CRISPR-Cas9-mediated genetic knockout human intestinal tissue-derived enteroid lines by lentivirus transduction and single-cell cloning. Nat Protoc. 2022 ;17(4):1004-1027.
Martins FH, Rajan A, Carter HE, Baniasadi HR, Maresso AW, Sperandio V. Interactions between Enterohemorrhagic Escherichia coli (EHEC) and Gut Commensals at the Interface of Human Colonoids. mBio. 2022 ;13(3):e0132122.
Piedra F-A, Henke D, Rajan A, Muzny DM, Doddapaneni H, Menon VK, et al.. Modeling nonsegmented negative-strand RNA virus (NNSV) transcription with ejective polymerase collisions and biased diffusion. Front Mol Biosci. 2022 ;9:1095193.
Rajan A, Piedra F-A, Aideyan L, McBride T, Robertson M, Johnson HL, et al.. Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection. J Virol. 2022 ;96(7):e0190421.
Chen J, Qiu X, Avadhanula V, Shepard SS, Kim D-K, Hixson J, et al.. Novel and extendable genotyping system for human respiratory syncytial virus based on whole-genome sequence analysis. Influenza Other Respir Viruses. 2022 ;16(3):492-500.
Blutt SE, Estes MK. Organoid Models for Infectious Disease. Annu Rev Med. 2022 ;73:167-182.
Liu Y, Kearney J, Mahmoud M, Kille B, Sedlazeck FJ, Treangen TJ. Rescuing low frequency variants within intra-host viral populations directly from Oxford Nanopore sequencing data. Nat Commun. 2022 ;13(1):1321.